# Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

> **NCT04462848** · PHASE1 · UNKNOWN · sponsor: **University of California, Los Angeles** · enrollment: 30 (estimated)

## Conditions studied

- Corona Virus Infection

## Interventions

- **BIOLOGICAL:** anti-SARS-CoV-2 human convalescent plasma

## Key facts

- **NCT ID:** NCT04462848
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462848, "Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04462848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*